EAGLE PHARMACEUTICALS INC's ticker is EGRX and the CUSIP is 269796108. A total of 179 filers reported holding EAGLE PHARMACEUTICALS INC in Q4 2019. The put-call ratio across all filers is 0.16 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2022 | $3,747,000 | -10.2% | 84,325 | 0.0% | 0.23% | +6.1% |
Q1 2022 | $4,173,000 | +32.9% | 84,325 | +36.7% | 0.21% | +91.9% |
Q4 2021 | $3,140,000 | -11.6% | 61,665 | -3.2% | 0.11% | -12.6% |
Q3 2021 | $3,552,000 | +24.6% | 63,685 | -4.4% | 0.13% | +29.6% |
Q2 2021 | $2,850,000 | -13.3% | 66,585 | -15.5% | 0.10% | -9.3% |
Q1 2021 | $3,288,000 | -13.6% | 78,771 | -3.6% | 0.11% | -27.5% |
Q4 2020 | $3,804,000 | +15.9% | 81,676 | +5.8% | 0.15% | -6.3% |
Q3 2020 | $3,281,000 | -8.9% | 77,231 | +2.9% | 0.16% | -9.7% |
Q2 2020 | $3,602,000 | -7.4% | 75,073 | -11.2% | 0.18% | -19.6% |
Q1 2020 | $3,891,000 | -7.9% | 84,577 | +20.2% | 0.22% | +37.7% |
Q4 2019 | $4,227,000 | -1.9% | 70,357 | -7.6% | 0.16% | -10.7% |
Q3 2019 | $4,308,000 | +5.4% | 76,160 | +3.8% | 0.18% | +10.6% |
Q2 2019 | $4,086,000 | +964.1% | 73,385 | +865.6% | 0.16% | +973.3% |
Q1 2019 | $384,000 | -42.7% | 7,600 | -40.9% | 0.02% | +7.1% |
Q4 2018 | $670,000 | +84.1% | 12,850 | +144.8% | 0.01% | 0.0% |
Q3 2018 | $364,000 | -15.2% | 5,250 | -7.3% | 0.01% | -22.2% |
Q2 2018 | $429,000 | +44.0% | 5,665 | 0.0% | 0.02% | +38.5% |
Q1 2018 | $298,000 | -23.8% | 5,665 | -22.6% | 0.01% | -18.8% |
Q4 2017 | $391,000 | +74.6% | 7,315 | +95.1% | 0.02% | +77.8% |
Q3 2017 | $224,000 | – | 3,750 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Tri Locum Partners LP | 94,922 | $4,063,000 | 1.33% |
Smith, Graham & Co., Investment Advisors, LP | 277,572 | $11,880,000 | 1.05% |
Krensavage Asset Management, LLC | 70,804 | $3,030,000 | 1.03% |
BRANDES INVESTMENT PARTNERS, LP | 716,873 | $30,682,000 | 0.68% |
GLOBEFLEX CAPITAL L P | 42,357 | $1,813,000 | 0.33% |
Zebra Capital Management LLC | 6,472 | $277,000 | 0.32% |
Capital Impact Advisors, LLC | 19,276 | $825,000 | 0.27% |
Hein Park Capital Management LP | 31,977 | $1,369,000 | 0.26% |
CHARTWELL INVESTMENT PARTNERS, LLC | 195,340 | $8,361,000 | 0.25% |
Stanley-Laman Group, Ltd. | 24,000 | $1,027,000 | 0.15% |